Pacific Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PACB and other ETFs, options, and stocks.

About PACB

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific.

CEO

Christian O. Henry

CEOChristian O. Henry

Employees

485

Employees485

Headquarters

Menlo Park, California

HeadquartersMenlo Park, California

Founded

2000

Founded2000

Employees

485

Employees485

PACB Key Statistics

Market cap

416.76M

Market cap416.76M

Price-Earnings ratio

-0.83

Price-Earnings ratio-0.83

Dividend yield

—

Dividend yield—

Average volume

5.51M

Average volume5.51M

High today

$1.57

High today$1.57

Low today

$1.36

Low today$1.36

Open price

$1.46

Open price$1.46

Volume

8.90M

Volume8.90M

52 Week high

$2.73

52 Week high$2.73

52 Week low

$0.8511

52 Week low$0.8511

Stock Snapshot

Pacific Biosciences(PACB) stock is priced at $1.37, giving the company a market capitalization of 416.76M. It carries a P/E multiple of -0.83.

During the trading session on 2026-03-06, Pacific Biosciences(PACB) shares reached a daily high of $1.57 and a low of $1.36. At a current price of $1.37, the stock is +0.7% higher than the low and still -12.7% under the high.

Trading volume for Pacific Biosciences(PACB) stock has reached 8.9M, versus its average volume of 5.51M.

Over the past 52 weeks, Pacific Biosciences(PACB) stock has traded between a high of $2.73 and a low of $0.85.

PACB News

TipRanks 34m

Pacific Biosciences Secures Key Patent License, Ends Litigation

Pacific Biosciences ( (PACB) ) has provided an update. On March 2, 2026, Pacific Biosciences said Chief Accounting Officer Michele Farmer had resigned effectiv...

TipRanks 11h

PacBio downgraded to Underweight from Equal Weight at Barclays

Barclays downgraded PacBio (PACB) to Underweight from Equal Weight with a price target of $1.50, down from $2. The shares have a “tough setup” over the near-ter...

TipRanks 1d

PacBio Adds AI-Driven Drug Discovery Leader to Board

An announcement from Pacific Biosciences ( (PACB) ) is now available. On March 3, 2026, PacBio’s board of directors expanded to ten members and appointed Chris...

Analyst ratings

50%

of 10 ratings

Buy

40%

Hold

50%

Sell

10%

More PACB News

TipRanks 1d

PacBio appoints Gibson to Board of Directors

PacBio (PACB) announced the appointment of Christopher Gibson, Ph.D., to PacBio’s Board of Directors. Dr. Gibson is the co-founder and Chairman of the Board of...

People also own

Based on the portfolios of people who own PACB. This list is generated using Robinhood data, and it’s not a recommendation.

CRISPR

NIO

Intellia Therapeutics

Plug Power

Editas Medicine

Bionano Genomics

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.